Association of hematuria on microscopic urinalysis and risk of urinary tract cancer

H. Jung, Joseph Gleason, R. K. Loo, H. S. Patel, J. M. Slezak, S. J. Jacobsen

Research output: Contribution to journalComment/debate

Abstract

Purpose: We determined the incidence of urinary tract cancer in patients with hematuria, stratified risk by age, gender and hematuria degree, and examined current best policy recommendations Materials and Methods: We performed a large, retrospective population based cohort study of patients who underwent microscopic urinalysis during 2004 and 2005 in a large managed care organization. Patients werefollowed for 3 years for urinary tract cancer Results: We identified 772,002 patients who underwent urinalysis during the study period. After exclusions due to previous hematuria, age less than 18 years, pregnancy, urinary tract infection, inpatient status and prior urinary tract cancer 309,402 patients were available for analysis, of whom 156,691 had hematuria. The overall 3-year incidence of urinary tract cancer in those with hematuria was 0.68%. Older age (greater than 40 years OR 17.0, 95% CI 11.2-25.7), greater hematuria (greater than 25 red blood cells per high power field OR 4.0, 95% CI 3.5-4.5) and male gender (OR 4.8, 95% CI 4.2-5.6) were associated with a higher risk of cancer. The American Urological Association definition of microhematuria had 50% sensitivity, 84% specificity and 1.3% positive predictive value. Conclusions: The incidence of urinary tract cancer is low even in individuals with microhematuria. Thus, current best policy recommendations do not perform well. Since older age, male gender and greater hematuria are associated with a higher risk of cancer, future studies should evaluate strategies that target these populations.

Original languageEnglish (US)
Pages (from-to)285-286
Number of pages2
JournalInternational Braz J Urol
Volume37
Issue number2
DOIs
StatePublished - Mar 1 2011

Fingerprint

Urologic Neoplasms
Urinalysis
Hematuria
Incidence
Health Services Needs and Demand
Managed Care Programs
Urinary Tract Infections
Inpatients
Neoplasms
Cohort Studies
Erythrocytes
Organizations
Sensitivity and Specificity
Pregnancy

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. / Jung, H.; Gleason, Joseph; Loo, R. K.; Patel, H. S.; Slezak, J. M.; Jacobsen, S. J.

In: International Braz J Urol, Vol. 37, No. 2, 01.03.2011, p. 285-286.

Research output: Contribution to journalComment/debate

Jung, H. ; Gleason, Joseph ; Loo, R. K. ; Patel, H. S. ; Slezak, J. M. ; Jacobsen, S. J. / Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. In: International Braz J Urol. 2011 ; Vol. 37, No. 2. pp. 285-286.
@article{591a2385ac124c12a435a4b0bdb1708b,
title = "Association of hematuria on microscopic urinalysis and risk of urinary tract cancer",
abstract = "Purpose: We determined the incidence of urinary tract cancer in patients with hematuria, stratified risk by age, gender and hematuria degree, and examined current best policy recommendations Materials and Methods: We performed a large, retrospective population based cohort study of patients who underwent microscopic urinalysis during 2004 and 2005 in a large managed care organization. Patients werefollowed for 3 years for urinary tract cancer Results: We identified 772,002 patients who underwent urinalysis during the study period. After exclusions due to previous hematuria, age less than 18 years, pregnancy, urinary tract infection, inpatient status and prior urinary tract cancer 309,402 patients were available for analysis, of whom 156,691 had hematuria. The overall 3-year incidence of urinary tract cancer in those with hematuria was 0.68{\%}. Older age (greater than 40 years OR 17.0, 95{\%} CI 11.2-25.7), greater hematuria (greater than 25 red blood cells per high power field OR 4.0, 95{\%} CI 3.5-4.5) and male gender (OR 4.8, 95{\%} CI 4.2-5.6) were associated with a higher risk of cancer. The American Urological Association definition of microhematuria had 50{\%} sensitivity, 84{\%} specificity and 1.3{\%} positive predictive value. Conclusions: The incidence of urinary tract cancer is low even in individuals with microhematuria. Thus, current best policy recommendations do not perform well. Since older age, male gender and greater hematuria are associated with a higher risk of cancer, future studies should evaluate strategies that target these populations.",
author = "H. Jung and Joseph Gleason and Loo, {R. K.} and Patel, {H. S.} and Slezak, {J. M.} and Jacobsen, {S. J.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1590/S1677-55382011000200027",
language = "English (US)",
volume = "37",
pages = "285--286",
journal = "International braz j urol : official journal of the Brazilian Society of Urology",
issn = "1677-5538",
publisher = "Brazilian Society of Urology",
number = "2",

}

TY - JOUR

T1 - Association of hematuria on microscopic urinalysis and risk of urinary tract cancer

AU - Jung, H.

AU - Gleason, Joseph

AU - Loo, R. K.

AU - Patel, H. S.

AU - Slezak, J. M.

AU - Jacobsen, S. J.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Purpose: We determined the incidence of urinary tract cancer in patients with hematuria, stratified risk by age, gender and hematuria degree, and examined current best policy recommendations Materials and Methods: We performed a large, retrospective population based cohort study of patients who underwent microscopic urinalysis during 2004 and 2005 in a large managed care organization. Patients werefollowed for 3 years for urinary tract cancer Results: We identified 772,002 patients who underwent urinalysis during the study period. After exclusions due to previous hematuria, age less than 18 years, pregnancy, urinary tract infection, inpatient status and prior urinary tract cancer 309,402 patients were available for analysis, of whom 156,691 had hematuria. The overall 3-year incidence of urinary tract cancer in those with hematuria was 0.68%. Older age (greater than 40 years OR 17.0, 95% CI 11.2-25.7), greater hematuria (greater than 25 red blood cells per high power field OR 4.0, 95% CI 3.5-4.5) and male gender (OR 4.8, 95% CI 4.2-5.6) were associated with a higher risk of cancer. The American Urological Association definition of microhematuria had 50% sensitivity, 84% specificity and 1.3% positive predictive value. Conclusions: The incidence of urinary tract cancer is low even in individuals with microhematuria. Thus, current best policy recommendations do not perform well. Since older age, male gender and greater hematuria are associated with a higher risk of cancer, future studies should evaluate strategies that target these populations.

AB - Purpose: We determined the incidence of urinary tract cancer in patients with hematuria, stratified risk by age, gender and hematuria degree, and examined current best policy recommendations Materials and Methods: We performed a large, retrospective population based cohort study of patients who underwent microscopic urinalysis during 2004 and 2005 in a large managed care organization. Patients werefollowed for 3 years for urinary tract cancer Results: We identified 772,002 patients who underwent urinalysis during the study period. After exclusions due to previous hematuria, age less than 18 years, pregnancy, urinary tract infection, inpatient status and prior urinary tract cancer 309,402 patients were available for analysis, of whom 156,691 had hematuria. The overall 3-year incidence of urinary tract cancer in those with hematuria was 0.68%. Older age (greater than 40 years OR 17.0, 95% CI 11.2-25.7), greater hematuria (greater than 25 red blood cells per high power field OR 4.0, 95% CI 3.5-4.5) and male gender (OR 4.8, 95% CI 4.2-5.6) were associated with a higher risk of cancer. The American Urological Association definition of microhematuria had 50% sensitivity, 84% specificity and 1.3% positive predictive value. Conclusions: The incidence of urinary tract cancer is low even in individuals with microhematuria. Thus, current best policy recommendations do not perform well. Since older age, male gender and greater hematuria are associated with a higher risk of cancer, future studies should evaluate strategies that target these populations.

UR - http://www.scopus.com/inward/record.url?scp=79959301259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959301259&partnerID=8YFLogxK

U2 - 10.1590/S1677-55382011000200027

DO - 10.1590/S1677-55382011000200027

M3 - Comment/debate

AN - SCOPUS:79959301259

VL - 37

SP - 285

EP - 286

JO - International braz j urol : official journal of the Brazilian Society of Urology

JF - International braz j urol : official journal of the Brazilian Society of Urology

SN - 1677-5538

IS - 2

ER -